Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
Diabetes/Metabolism Research and Reviews|September 3, 2004
Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetesMark S Fineman, Larry Z Shen, Kristin Taylor, et al.Journal of Clinical Pharmacology|April 28, 2007
Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetesTerrie A Kellmeyer, Nicole C Kesty, Yan Wang, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 15, 2000
Changing trends in paintball sport-related ocular injuriesM S Fineman, D H Fischer, J B Jeffers, et al.Retina (Philadelphia, Pa.)|August 14, 2008
Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyesJason Hsu, Eric Chen, Omesh Gupta, et al.Frontiers in Sleep|April 8, 2024
Forward and Back is Not Enough: Applying Best Practices for Translation of Pediatric Sleep QuestionnairesDarcy A Thompson, Melissa S Fineman, Estefania Miramontes Valdes, et al.Ophthalmology|March 21, 1998
Melanocytomalytic glaucoma in eyes with necrotic iris melanocytomaM S Fineman, R C Eagle, J A Shields, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 10, 2005
Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetesK Taylor, D Kim, L L Nielsen, et al.Diabetes, Obesity & Metabolism|August 6, 2025
GLY-200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double-blind placebo-controlled trialChristine L N Bryant, Kevin Colbert, Marcus Hompesch, et al.American Journal of Ophthalmology|February 1, 2000
Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusionG K Shah, S Sharma, M S Fineman, et al.Diabetes Care|April 28, 2005
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetesRalph A DeFronzo, Robert E Ratner, Jenny Han, et al.Pageof 9